Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2011-07-21Clinical Trial Update: Fall Prevention by Alfacalcidol and Training [Phase 4]
Phase 4 trial evaluating fall prevention with alfacalcidol and training has been withdrawn, involving older adults with chronic kidney disea…
-
CLINICAL_TRIALS withdrawal · 2011-04-19Clinical Trial Update: Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia [Phase 2]
A Phase 2 trial evaluating subcutaneous rilonacept for non-dialysis-dependent chronic kidney disease with anemia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2010-10-19Clinical Trial Update: Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride [Phase 3]
Phase 3 trial evaluating Fermagate in combination with Sevelamer Hydrochloride for chronic kidney disease was terminated.
-
CLINICAL_TRIALS withdrawal · 2009-02-12Clinical Trial Update: REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial [Phase 3]
The REPEAT Study, a Phase 3 trial evaluating a resistance-to-erythropoietin effectiveness algorithm in chronic kidney disease, has been term…
-
CLINICAL_TRIALS withdrawal · 2008-10-01Clinical Trial Update: Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating rosiglitazone for anti-inflammatory effects in patients with Stage 4-5 chronic kidney disease ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.